Valuation: ZIM Laboratories Limited

Market Cap 6.43B 66.38M 58.38M 54.24M 49.88M 93.55M 95.23M 649M 253M 3.14B 249M 244M 10.88B P/E 2025
32.1x
P/E 2026 50.3x
Enterprise Value 7.29B 75.29M 66.22M 61.52M 56.58M 106M 108M 736M 287M 3.56B 283M 277M 12.34B EV / Sales 2025
1.34x
EV / Sales 2026 1.09x
Free-Float
28.79%
Yield 2025 *
-
Yield 2026 -
1 day-2.00%
1 week-0.50%
Current month-3.42%
1 month-4.27%
3 months+38.26%
6 months+68.89%
Current year+66.99%
1 week 120.05
Extreme 120.05
125.5
1 month 111.5
Extreme 111.5
133.95
Current year 59.72
Extreme 59.72
133.95
1 year 59.72
Extreme 59.72
133.95
3 years 59.72
Extreme 59.72
151.75
5 years 36.37
Extreme 36.3667
151.75
10 years 14
Extreme 14
151.75
Manager TitleAgeSince
Chief Executive Officer - 2001-12-31
Director of Finance/CFO - 2019-03-31
Director of Finance/CFO - 1990-12-31
Director TitleAgeSince
Chairman - 1989-12-31
Director/Board Member - 1990-12-31
Director/Board Member - 2012-12-31
Change 5-day change 1-year change 3-year change Capi.($)
-2.00%-0.50%+2.91%+0.04% 67.98M
+0.57%+0.13%+16.45%+78.10% 48.31B
-0.50%-0.41%+67.13%+107.90% 35.33B
-1.56%-3.13%-4.88%+32.80% 11.85B
-1.11%-3.73%+16.41%+81.64% 11.64B
-0.84%-0.19%+36.48%+136.73% 8.99B
-0.27%+0.42%+51.66%-6.22% 6.93B
-0.77%-3.00%+13.55%+32.01% 6.72B
+0.24%-4.02%+2.19%+192.78% 6.43B
+1.60%-9.55%-30.77%+8.47% 5.66B
Average -0.45%-1.21%+17.11%+66.43% 14.19B
Weighted average by Cap. -0.17%-0.93%+27.59%+81.82%

Financials

2025 2026
Net sales 3.79B 39.15M 34.43M 31.99M 29.42M 55.17M 56.16M 383M 149M 1.85B 147M 144M 6.42B 3.74B 38.66M 34M 31.59M 29.05M 54.48M 55.46M 378M 147M 1.83B 145M 142M 6.34B
Net income 122M 1.26M 1.1M 1.03M 944K 1.77M 1.8M 12.27M 4.79M 59.34M 4.72M 4.61M 206M 58.38M 603K 530K 493K 453K 850K 865K 5.89M 2.3M 28.48M 2.26M 2.21M 98.79M
Net Debt 1.16B 11.95M 10.51M 9.77M 8.98M 16.85M 17.15M 117M 45.55M 565M 44.88M 43.91M 1.96B 863M 8.91M 7.84M 7.28M 6.7M 12.56M 12.78M 87.07M 33.96M 421M 33.46M 32.73M 1.46B
Logo ZIM Laboratories Limited
ZIM Laboratories Limited is a pharmaceutical company. The Company develops, manufactures and supplies oral, solid differentiated generic pharmaceutical formulations and pre-formulation intermediaries (PFI) in various therapeutic segments. Its delivery solutions cover product conceptualization product development, filing for registration, manufacture, and supply of various pharmaceutical formulations. It is developing products in various therapeutic segments like, central nervous system, anti-biotic and anti-infective, gastrointestinal, cardiovascular, analgesic/pain management, urology and vitamins, minerals, and dietary supplements. Its technological capabilities include drug release modification, solubility and stability enhancement, taste masking and dosage form transformation. Its product offerings include finished formulations and pre-formulations intermediates, which include granules, pellets, taste-masked powders, dry suspensions, tablets, capsules, and oral thin films.
Employees
632
Date Price Change Volume
26-07-23 120.05 -2.00% 500
26-07-21 ₹122.50 -2.00% 400
26-07-20 ₹125.00 -0.36% 2,296
26-07-17 ₹125.45 +1.95% 8,530
26-07-16 ₹123.05 +1.99% 3,069
  1. Stock Market
  2. Stocks
  3. ZIMLAB Stock